1.
Stein
DT
,
Esser
V
,
Stevenson
BE
, et al.
Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat . J Clin Invest.
1996; ; 97 : :2728.–2735.
2.
Nolan
CJ
,
Madiraju
MS
,
Delghingaro-Augusto
V
, et al.
Fatty acid signaling in the {beta}-cell and insulin secretion . Diabetes.
2006; ; 55 : :S16.–23.
3.
Briscoe
CP
,
Tadayyon
M
,
Andrews
JL
, et al.
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids . J Biol Chem.
2003; ; 278 : :11303.–11311.
4.
Itoh
Y
,
Kawamata
Y
,
Harada
M
, et al.
Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40 . Nature.
2003; ; 422 : :173.–176.
5.
Hirasawa
A
,
Tsumaya
K
,
Awaji
T
, et al.
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 . Nat Med.
2005; ; 11 : :90.–94.
6.
Nilsson
NE
,
Kotarsky
K
,
Owman
C
,
Olde
B
. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids . Biochem Biophys Res Commun.
2003; ; 303 : :1047.–1052.
7.
Le Poul
E
,
Loison
C
,
Struyf
S
, et al.
Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation . J Biol Chem.
2003; ; 278 : :25481.–25489.
8.
Wang
J
,
Wu
X
,
Simonavicius
N
, et al.
Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84 . J Biol Chem.
2006; ; 281 : :34457.–34464.
9.
Overton
HA
,
Babbs
AJ
,
Doel
SM
, et al.
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents . Cell Metab.
2006; ; 3 : :167.–175.
10.
Mancini
AD
,
Poitout
V
. The fatty acid receptor FFA1/GPR40 a decade later : how much do we know?
Trends Endocrinol Metab.
2013 ; doi :
10.1016/j.tem.2013.03.003.
11.
Nagasumi
K
,
Esaki
R
,
Iwachidow
K
, et al.
Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice . Diabetes.
2009; ; 58 : :1067.–1076.
12.
Vettor
R
,
Granzotto
M
,
De Stefani
D
, et al.
Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization . J Clin Endocrinol Metab.
2008; ; 93 : :3541.–3550.
13.
Poitout
V
,
Amyot
J
,
Semache
M
, et al.
Glucolipotoxicity of the pancreatic beta cell . Biochim Biophys Acta.
2010; ; 1801 : :289.–298.
14.
Steneberg
P
,
Rubins
N
,
Bartoov-Shifman
R
, et al.
The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse . Cell Metabol.
2005; ; 1 : :245.–258.
15.
Alquier
T
,
Poitout
V
. GPR40 : good cop, bad cop?
Diabetes.
2009; ; 58 : :1035.–1036.
16.
Tan
CP
,
Feng
Y
,
Zhou
YP
, et al.
Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice . Diabetes.
2008; ; 57 : :2211.–2219.
17.
Tsujihata
Y
,
Ito
R
,
Suzuki
M
, et al.
TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats . J Pharmacol Exp Ther.
2011; ; 339 : :228.–237.
18.
Lin
DC
,
Zhang
J
,
Zhuang
R
, et al.
AMG 837 : a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents . PLoS One.
2011; ; 6 : :e27270..
19.
Luo
J
,
Swaminath
G
,
Brown
SP
, et al.
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents . PLoS One.
2012; ; 7 : :e46300..
20.
Burant
CF
,
Viswanathan
P
,
Marcinak
J
, et al.
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus : a phase 2, randomised, double-blind, placebo-controlled trial . Lancet.
2012; ; 379 : :1403.–1411.
21.
Kaku
K
,
Araki
T
,
Yoshinaka
R
. Randomized, double-Blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes . Diabetes Care.
2013; ; 36 : :245.–250.
22.
Liou
AP
,
Lu
X
,
Sei
Y
, et al.
The G protein-coupled receptor GPR40 directly mediates long chain fatty acid-induced secretion of cholecystokinin . Gastroenterology.
2011; ; 140 : :903.–912.
23.
Edfalk
S
,
Steneberg
P
,
Edlund
H
. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion . Diabetes.
2008; ; 57 : :2280.–2287.
24.
Flodgren
E
,
Olde
B
,
Meidute-Abaraviciene
S
, et al.
GPR40 is expressed in glucagon producing cells and affects glucagon secretion . Biochem Biophys Res Commun.
2007; ; 354 : :240.–245.
25.
Hirasawa
A
,
Itsubo
C
,
Sadakane
K
, et al.
Production and characterization of a monoclonal antibody against GPR40 (FFAR1; free fatty acid receptor 1) . Biochem Biophys Res Commun.
2008; ; 365 : :22.–28.
26.
Wang
L
,
Zhao
Y
,
Gui
B
, et al.
Acute stimulation of glucagon secretion by linoleic acid results from GPR40 activation and [Ca2+]i increase in pancreatic islet (alpha)-cells . J Endocrinol.
2011; ; 210 : :173.–179.
27.
Yashiro
H
,
Tsujihata
Y
,
Takeuchi
K
, et al.
The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets . J Pharmacol Exp Ther.
2012; ; 340 : :483.–489.
28.
Tanaka
T
,
Katsuma
S
,
Adachi
T
, et al.
Free fatty acids induce cholecystokinin secretion through GPR120 . Naunyn-Schmiedeberg’s Arch Pharmacol.
2008; ; 377 : :523.–527.
29.
Oh da
Y
,
Talukdar
S
,
Bae
EJ
, et al.
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects . Cell.
2010; ; 142 : :687.–698.
30.
Ichimura
A
,
Hirasawa
A
,
Poulain-Godefroy
O
, et al.
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human . Nature.
2012; ; 483 : :350.–354.
31.
Kebede
MA
,
Alquier
T
,
Latour
MG
,
Poitout
V
. Lipid receptors and islet function : therapeutic implications?
Diabetes Obes Metab.
2009; ; 11 : :10.–20.
32.
Taneera
J
,
Lang
S
,
Sharma
A
, et al.
A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets . Cell Metabolism.
2012; ; 16 : :122.–134.
33.
Martin
C
,
Passilly-Degrace
P
,
Chevrot
M
, et al.
Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae : putative involvement of GPR120 and impact on taste sensitivity . J Lipid Res.
2012; ; 53 : :2256.–2265.
34.
Kaji
I
,
Karaki
S
,
Tanaka
R
,
Kuwahara
A
. Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide . J Mol Histol.
2011; ; 42 : :27.–38.
35.
Tolhurst
G
,
Heffron
H
,
Lam
YS
, et al.
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2 . Diabetes.
2012; ; 61 : :364.–371.
36.
Brown
AJ
,
Goldsworthy
SM
,
Barnes
AA
, et al.
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids . J Biol Chem.
2003; ; 278 : :11312.–11319.
37.
Maslowski
KM
,
Vieira
AT
,
Ng
A
, et al.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 . Nature.
2009; ; 461 : :1282.–1286.
38.
Hong
YH
,
Nishimura
Y
,
Hishikawa
D
, et al.
Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43 . Endocrinology.
2005; ; 146 : :5092.–5099.
39.
Zaibi
MS
,
Stocker
CJ
,
O’Dowd
J
, et al.
Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids . FEBS Lett.
2010; ; 584 : :2381.–2386.
40.
Ge
H
,
Li
X
,
Weiszmann
J
, et al.
Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids . Endocrinology.
2008; ; 149 : :4519.–4526.
41.
Ximenes
HMA
,
Hirata
AE
,
Rocha
MS
, et al.
Propionate inhibits glucose-induced insulin secretion in isolated rat pancreatic islets . Cell Biochem Funct.
2007; ; 25 : :173.–178.
42.
Schmidt
J
,
Smith
NJ
,
Christiansen
E
, et al.
Selective orthosteric free fatty acid receptor 2 (FFA2) agonists : identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3 . J Biol Chem.
2011; ; 286 : :10628.–10640.
43.
Chu
ZL
,
Jones
RM
,
He
H
, et al.
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release . Endocrinology.
2007; ; 148 : :2601.–2609.
44.
Chu
ZL
,
Carroll
C
,
Chen
R
, et al.
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119 . Mol Endocrinol.
2010; ; 24 : :161.–170.
45.
Lauffer
LM
,
Iakoubov
R
,
Brubaker
PL
. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell . Diabetes.
2009; ; 58 : :1058.–1066.
46.
Lan
H
,
Vassileva
G
,
Corona
A
, et al.
GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis . J Endocrinol.
2009; ; 201 : :219.–230.
47.
Alquier
T
,
Peyot
ML
,
Latour
MG
, et al.
Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets . Diabetes.
2009; ; 58 : :2607.–2615.
48.
Ferdaoussi
M
,
Bergeron
V
,
Zarrouki
B
, et al.
G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1 . Diabetologia.
2012; ; 55 : :2682.–2692.
49.
Watson
SJ
,
Brown
AJH
,
Holliday
ND
. Differential signaling by splice variants of the human free fatty acid receptor GPR120 . Mol Pharmacol.
2012; ; 81 : :631.–642.
50.
Ning
Y
,
O’Neill
K
,
Lan
H
, et al.
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells . Br J Pharmacol.
2008; ; 155 : :1056.–1065.
51.
Naik
H
,
Vakilynejad
M
,
Wu
J
, et al.
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875 : results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers . J Clin Pharmacol.
2012; ; 52 : :1007.–1016.
52.
Lin
DC
,
Guo
Q
,
Luo
J
, et al.
Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor . Mol Pharmacol.
2012; ; 82 : :843.–859.
53.
Ohishi
T
,
Yoshida
S
. The therapeutic potential of GPR119 agonists for type 2 diabetes . Expert Opin Investig Drugs.
2012; ; 21 : :321.–328.
54.
Lauffer
L
,
Iakoubov
R
,
Brubaker
PL
. GPR119 : Double-dipping for better glycemic control . Endocrinology.
2008; ; 149 : :2035.–2037.
55.
Katz
LB
,
Gambale
JJ
,
Rothenberg
PL
, et al.
Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes . Diabetes Obes Metab.
2012; ; 14 : :709.–716.
56.
Ulven
T.
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets . Front Endocrinol.
2012; ; 3 : :111..